The COVID-19 pandemic has far-reaching impacts on global health product supply chains. The Global Fund works closely with suppliers, implementers and partners to assess the impact on core health product supplies for Global Fund grants. We provide recommendations for implementers on how to manage this impact and offer channels to ensure the continued flow of quality-assured health products.
As of 22 March 2021, the Global Fund’s product and delivery outlook shows the overall impact of COVID-19 on health product supply chains for Global Fund grants remains at moderate.
Our health product supply response to the pandemic includes regular category-by-category operational risk assessments, recommendations for implementers and other actions. The resource below details our latest assessment and recommendations.
Health products are a critical component of a country’s effective emergency response to COVID-19. Countries can access support to secure products through the COVID-19 Response Mechanism. Our documents and pages detail procurement for: